Topic Hub
29 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 29 of 29 clinical reviews.
Is it safe to take Addyi (flibanserin) with acetaminophen? A physician-reviewed guide covering CYP3A4 metabolism, hepatic risk, CNS effects, dose limits, and monitoring recommendations.
Read clinical reviewCan you take Addyi with finasteride? A physician-reviewed guide covering CYP3A4 metabolism, androgen pathway overlap, severity rating, monitoring protocols, and dose-adjustment recommendations.
Read clinical reviewA clinical review of the flibanserin, levothyroxine drug interaction covering CYP3A4 metabolism, absorption timing, severity rating, monitoring parameters, and practical dosing guidance.
Read clinical reviewBoard-reviewed clinical guide to taking Addyi (flibanserin) with metformin. Covers CYP metabolism, severity rating, monitoring parameters, dose adjustments, and patient counseling.
Read clinical reviewClinical guide to combining flibanserin (Addyi) with proton pump inhibitors like omeprazole and pantoprazole. Covers CYP metabolism, severity rating, dose adjustments, and physician-backed monitoring advice.
Read clinical reviewCan you take Addyi (flibanserin) with progesterone HRT? Learn about the sedation overlap, CYP3A4 considerations, monitoring protocols, and dose-adjustment guidance backed by FDA labeling and primary literature.
Read clinical reviewClinical analysis of the flibanserin-rivaroxaban drug interaction, including CYP3A4 mechanism, severity rating, monitoring parameters, and dose-adjustment strategies for prescribers and patients.
Read clinical reviewA clinician-level review of the flibanserin (Addyi) and apixaban drug interaction, covering CYP3A4 and P-glycoprotein mechanisms, bleeding risk, severity classification, monitoring parameters, and patient counseling points.
Read clinical reviewA clinician-reviewed guide to the flibanserin, bupropion drug interaction, covering CYP2D6 inhibition, blood-level changes, side-effect risks, dose adjustments, and monitoring protocols.
Read clinical reviewCan you take Addyi (flibanserin) with clopidogrel? Learn about the CYP2C19-mediated drug interaction, clinical risks, monitoring requirements, and dose-adjustment guidance.
Read clinical reviewCan you take flibanserin (Addyi) with diphenhydramine? Learn about CNS depression risks, CYP2D6 interactions, severity ratings, and safer alternatives for premenopausal women.
Read clinical reviewCan you take Addyi (flibanserin) with estradiol HRT? A physician-reviewed guide covering CYP3A4 pharmacokinetics, cardiovascular overlap risks, monitoring protocols, and dose-adjustment strategies.
Read clinical reviewCan you take Addyi (flibanserin) with gabapentin? Review the pharmacologic interaction profile, CNS depression risk, dose adjustments, and monitoring recommendations backed by FDA labeling and primary literature.
Read clinical reviewClinical review of the flibanserin (Addyi) and hormonal contraceptives interaction, including CYP3A4 pharmacokinetics, FDA label data, safety profile, and prescriber guidance.
Read clinical reviewA physician-reviewed guide to the flibanserin and NSAID drug interaction, covering mechanism, GI and renal risks, monitoring, dose guidance, and patient counseling.
Read clinical reviewA clinician-reviewed guide to the flibanserin, prednisone drug interaction, covering CYP3A4 mechanisms, hypotension risk, CNS depression, blood glucose effects, and practical monitoring steps for women on both drugs.
Read clinical reviewCan you take Addyi (flibanserin) with pregabalin? Learn about the pharmacodynamic interaction, CNS depression risks, severity rating, dose adjustments, and monitoring recommendations backed by FDA labeling and clinical evidence.
Read clinical reviewA physician-reviewed deep dive into the flibanserin and rosuvastatin drug interaction, covering mechanism, severity, monitoring, dose adjustments, and patient counseling.
Read clinical reviewCombining flibanserin (Addyi) with sildenafil carries a clinically significant hypotension risk. Learn the mechanism, severity, monitoring steps, and safer alternatives backed by FDA labeling and primary literature.
Read clinical reviewFlibanserin (Addyi) and simvastatin share the CYP3A4 metabolic pathway, raising the risk of increased statin exposure and side effects. Learn the mechanism, severity, monitoring, and dose-adjustment guidance.
Read clinical reviewA clinical deep-dive into the flibanserin-SNRI drug interaction, covering serotonin syndrome risk, CYP2C19 pharmacokinetics, blood pressure effects, monitoring protocols, and patient counseling for venlafaxine and duloxetine co-administration.
Read clinical reviewFlibanserin (Addyi) combined with SSRIs like sertraline or escitalopram raises serotonin syndrome risk and may worsen CNS depression. Learn the mechanism, severity rating, monitoring protocol, and safer alternatives from HealthRX.com clinicians.
Read clinical reviewCan you take flibanserin (Addyi) with tadalafil (Cialis)? A physician-reviewed guide covering the pharmacokinetic and pharmacodynamic interaction, hypotension risk, monitoring protocols, and dose-adjustment strategies.
Read clinical reviewCan you take Addyi (flibanserin) with testosterone? Learn about the pharmacokinetic and pharmacodynamic interactions, safety concerns, monitoring requirements, and clinical evidence behind combining these two treatments for hypoactive sexual desire disorder.
Read clinical reviewCombining flibanserin (Addyi) with trazodone carries real risks of CNS depression, hypotension, and serotonin excess. Learn the mechanism, severity, monitoring steps, and safer alternatives from HealthRX clinicians.
Read clinical reviewCombining flibanserin (Addyi) with zolpidem carries a clinically significant risk of additive CNS depression. Learn the mechanism, severity, monitoring steps, and what your prescriber needs to know.
Read clinical reviewEvidence-based guide to the flibanserin-benzodiazepine interaction covering CNS depression risk, CYP3A4 pharmacokinetics, dose adjustments, and patient counseling from the FDA label and primary literature.
Read clinical reviewDetailed clinical guide on the interaction between flibanserin (Addyi) and opioids including oxycodone, hydrocodone, and tramadol. Covers CNS depression risk, CYP metabolism, dose adjustments, and monitoring.
Read clinical reviewBoard-certified physician-reviewed guide to the flibanserin and warfarin drug interaction, covering CYP metabolism, INR monitoring, clinical trial data, and practical patient counseling.
Read clinical review